Table 2.
Fatty Acids * | No Bone Metastasis n = 78 | Bone Metastasis n = 21 | Statistics | |||
---|---|---|---|---|---|---|
Mean | Range | Mean | Range | p | ||
Saturated | ||||||
Myristic acid | 14:0 | 3.47 | 1.65–4.90 | 3.56 | 2.47–4.72 | 0.14 |
Palmitic acid | 16:0 | 23.61 | 19.63–28.8 | 23.9 | 21.01–26.63 | 0.52 |
Stearic acid | 18:0 | 6.02 | 3.20–8.33 | 5.96 | 3.03–8.57 | 0.86 |
Total SFA | 34.11 | 25.97–40.62 | 34.37 | 29.85–40.12 | 0.68 | |
Monounsaturated | ||||||
Myristoleic acid | 14:1 | 0.27 | 0.01–0.56 | 0.30 | 0.14–0.60 | 0.38 |
Palmitoleic acid | 16:1 | 3.34 | 1.09–8.45 | 3.56 | 1.80–6.89 | 0.54 |
Oleic acid | 18:1n-9c | 43.23 | 38.01–47.65 | 43.17 | 38.13–48.11 | 0.91 |
Vaccenic acid | 18:1n-7c | 1.79 | 1.25–2.86 | 1.81 | 1.39–2.56 | 0.81 |
Total MUFA | 49.94 | 42.48–56.19 | 50.15 | 45.92–55.71 | 0.77 | |
Polyunsaturated | ||||||
Linoleic acid | 18:2n-6c | 10.63 | 6.43–21.0 | 10.37 | 7.39–15.05 | 0.59 |
Gamma linolenic acid | 18:3n-6 | 0.04 | 0.02–0.09 | 0.04 | 0.02–0.06 | 0.31 |
Arachidonic acid | 20:4n-6 | 0.29 | 0.15–0.63 | 0.30 | 0.16–0.60 | 0.92 |
LC PUFA n-6 | 0.91 | 0.45–2.06 | 0.88 | 0.50-1.55 | 0.71 | |
Total n-6 | 11.61 | 6.94–22.68 | 11.33 | 8.30–16.22 | 0.57 | |
Alpha linolenic acid | 18:3n-3 | 0.60 | 0.29–1.04 | 0.58 | 0.37–0.98 | 0.62 |
Eicosapentaenoic acid | 20:5n-3 | 0.07 | 0.02–0.16 | 0.06 | 0.03–0.11 | 0.15 |
Docosapentaenoic acid | 22:5n-3 | 0.19 | 0.05–0.51 | 0.16 | 0.07–0.24 | 0.03 |
Docosahexaenoic acid | 22:6n-3 | 0.16 | 0.03–0.35 | 0.13 | 0.05–0.21 | 0.06 |
LC PUFA n-3 | 0.42 | 0.12–0.97 | 0.36 | 0.16–0.49 | 0.02 | |
Total n-3 | 1.05 | 0.63–1.52 | 0.97 | 0.60–1.43 | 0.11 | |
n-6/n-3 ratio | n-6/n-3 | 11.41 | 7.26–26.91 | 11.98 | 7.69–20.07 | 0.44 |
* expressed as % area, SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated fatty acids, LC PUFA: long-chain polyunsaturated fatty acids.